Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -372.74% is 19% below its 5-year average of -313.54%, near the high end of its 5-year range (-2895.84%–52.79%).
15.43% below its 12-month average of -322.91%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -585.39%.
EBITDA MARGIN
-372.74%
EBITDA MARGIN AVG TTM
-322.91%
EBITDA MARGIN AVG 3Y
-274.16%
EBITDA MARGIN AVG 5Y
-313.54%
EBITDA MARGIN AVG 10Y
-399.31%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-15.43%
CURRENT VS 3Y AVG
-35.96%
CURRENT VS 5Y AVG
-18.88%
CURRENT VS 10Y AVG
+6.65%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jaguar Health, Inc.
Market Cap
$2.56M
EBITDA Margin
-372.74%
TTM Avg
-322.91%
3Y Avg
-274.16%
5Y Avg
-313.54%
Market Cap
$2.64M
EBITDA Margin
-375.69%
TTM Avg
-244.00%
3Y Avg
-166.51%
5Y Avg
-121.60%
Market Cap
$2.58M
EBITDA Margin
-163.38%
TTM Avg
-126.27%
3Y Avg
-20964.27%
5Y Avg
-20964.27%
Market Cap
$2.61M
EBITDA Margin
-129.25%
TTM Avg
-125.71%
3Y Avg
-160.72%
5Y Avg
-184.50%
Market Cap
$2.58M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.04M
EBITDA Margin
-22711.52%
TTM Avg
-15924.10%
3Y Avg
-12940.13%
5Y Avg
-12940.13%
Market Cap
$2.32M
EBITDA Margin
-100324.78%
TTM Avg
-75768.79%
3Y Avg
-56097.78%
5Y Avg
-38080.91%
Market Cap
$2.33M
EBITDA Margin
-776.30%
TTM Avg
-1492.64%
3Y Avg
-21514.87%
5Y Avg
-21514.87%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.56M | -372.74% | -322.91% | -274.16% | -313.54% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -375.69% | -244.00% | -166.51% | -121.60% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.58M | -163.38% | -126.27% | -20964.27% | -20964.27% |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | -129.25% | -125.71% | -160.72% | -184.50% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.58M | N/A | N/A | N/A | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.47M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | -22711.52% | -15924.10% | -12940.13% | -12940.13% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -100324.78% | -75768.79% | -56097.78% | -38080.91% |
| Onconetix, Inc. (ONCO)vs › | $2.33M | -776.30% | -1492.64% | -21514.87% | -21514.87% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -4291.67% | -3563.06% | -8274.29% | -15578.54% |
Gross Margin
67.2%
EBITDA Margin
-372.7%
Operating Margin
-391.9%
Net Margin
-131.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -585.39% |
| 2026-03-31 | 52.79% |
| 2025-12-31 | -615.12% |
| 2025-09-30 | -216.70% |
| 2025-06-30 | -250.12% |
| 2025-03-31 | -400.86% |
| 2024-12-31 | -215.56% |
| 2024-09-30 | -214.48% |
| 2024-06-30 | -243.95% |
| 2024-03-31 | -323.48% |
| 2023-12-31 | -306.74% |
| 2023-09-30 | -290.15% |
| 2023-06-30 | -279.56% |
| 2023-03-31 | -471.30% |
| 2022-12-31 | -174.36% |
| 2022-09-30 | -295.52% |
| 2022-06-30 | -199.62% |
| 2022-03-31 | -430.44% |
| 2021-12-31 | -496.63% |
| 2021-09-30 | -1437.46% |
| 2021-06-30 | -2895.84% |
| 2021-03-31 | -671.64% |
| 2020-12-31 | -183.85% |
| 2020-09-30 | -171.44% |
| 2020-06-30 | -247.74% |
| 2020-03-31 | -809.09% |
| 2019-12-31 | -381.83% |
| 2019-09-30 | -627.50% |
| 2019-06-30 | -579.22% |
| 2019-03-31 | -332.24% |
| 2018-12-31 | -738.19% |
| 2018-09-30 | -545.58% |
| 2018-06-30 | -763.64% |
| 2018-03-31 | -596.59% |
| 2017-12-31 | -1324.41% |
| 2017-09-30 | -640.23% |
| 2017-06-30 | -260.48% |
| 2017-03-31 | -469.42% |
| 2016-12-31 | -11424.37% |
| 2016-09-30 | -6282.73% |
| 2016-06-30 | -14077.79% |
| 2016-03-31 | -9638.97% |
| 2015-12-31 | 2377.48% |
| 2015-09-30 | -3546.65% |
| 2015-06-30 | -4743.64% |
| 2015-03-31 | -3772.48% |
